Bookedited by Elia Duh.
Contents:
1 Nonproliferative diabetic retinopathy
2 Proliferative diabetic retinopathy
3 The epidemiology of diabetic retinopathy
4 Diagnostic modalities in diabetic retinopathy
5 In vivo models of diabetic retinopathy
6 The polyol pathway and diabetic retinopathy
7 The role of advanced glycation in diabetic retinopathy
8 The role of protein kinase C in diabetic retinopathy
9 Oxidative stress in diabetic retinopathy
10 Pericyte loss in the diabetic retina
11 Capillary dropout in diabetic retinopathy
12 Neuroglial dysfunction in the pathophysiology of diabetic retinopathy
13 The role of inflammation in the pathophysiology of diabetic retinopathy
14 Vascular permeability in diabetic retinopathy
15 Retinal neovascularization and the role of VEGF
16 Beyond VEGF: other factors important in retinal neovascularization: potential targets in proliferative diabetic retinopathy
17 Anti-VEGF therapy as an emerging treatment for diabetic retinopathy
18 Clinical trials in protein kinase C-Beta inhibition in diabetic retinopathy
19 The role of intravitreal steroids in the management of diabetic retinopathy
20 Antagonism of the growth hormone axis as a therapeutic strategy for diabetic retinopathy
21 Diabetic retinopathy and systemic complications.